Evolus Profit Margin 2016-2018 | EOLS
Current and historical gross margin, operating margin and net profit margin for Evolus (EOLS) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Evolus net profit margin as of December 31, 2018 is 0%.
|Evolus Annual Profit Margins
|Evolus Quarterly Profit Margins
||Medical Products Manufacturing
Evolus, Inc. is a medical aesthetics company. It focuses on providing physicians and patients in aesthetic procedures and treatments. The company focuses on the self-pay aesthetic market and its lead product candidate, DWP-450, is an injectable 900 kDa purified botulinum toxin type A complex. Evolus, Inc. is based in Irvine, California.